Diabetes Therapy最新文献

筛选
英文 中文
Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease 基于心血管结局试验的恩格列净与西格列汀和沙格列汀在2型糖尿病和已确诊心血管疾病患者中的成本-效果分析
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-10-10 DOI: 10.1007/s13300-019-00701-3
M. Ramos, V. Foos, A. Ustyugova, N. Hau, P. Gandhi, M. Lamotte
{"title":"Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease","authors":"M. Ramos, V. Foos, A. Ustyugova, N. Hau, P. Gandhi, M. Lamotte","doi":"10.1007/s13300-019-00701-3","DOIUrl":"https://doi.org/10.1007/s13300-019-00701-3","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"2153 - 2167"},"PeriodicalIF":3.8,"publicationDate":"2019-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00701-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44859707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK 英国2型糖尿病患者心血管疾病的患病率
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-10-04 DOI: 10.1007/s13300-019-00698-9
D. Lautsch, Tongtong Wang, Lingfeng Yang, S. Rajpathak
{"title":"Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK","authors":"D. Lautsch, Tongtong Wang, Lingfeng Yang, S. Rajpathak","doi":"10.1007/s13300-019-00698-9","DOIUrl":"https://doi.org/10.1007/s13300-019-00698-9","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"2131 - 2137"},"PeriodicalIF":3.8,"publicationDate":"2019-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00698-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41635232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Correction to: Cardiac Autonomic Neuropathy in Obesity, Metabolic Syndrome and Prediabetes: A Narrative Review 更正:肥胖、代谢综合征和糖尿病前期的心脏自主神经病变:叙述性综述
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-10-04 DOI: 10.1007/s13300-019-00705-z
Scott M. Williams, Aikaterini Eleftheriadou, U. Alam, D. Cuthbertson, John P H Wilding
{"title":"Correction to: Cardiac Autonomic Neuropathy in Obesity, Metabolic Syndrome and Prediabetes: A Narrative Review","authors":"Scott M. Williams, Aikaterini Eleftheriadou, U. Alam, D. Cuthbertson, John P H Wilding","doi":"10.1007/s13300-019-00705-z","DOIUrl":"https://doi.org/10.1007/s13300-019-00705-z","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"2023 - 2023"},"PeriodicalIF":3.8,"publicationDate":"2019-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00705-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49093028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections CGM评估利拉鲁肽对每日多次胰岛素注射治疗的2型糖尿病患者血糖范围内时间的影响
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-09-28 DOI: 10.1007/s13300-019-00692-1
Sheyda Sofizadeh, Henrik Imberg, A. F. Ólafsdóttir, M. Ekelund, S. Dahlqvist, I. Hirsch, K. Filipsson, B. Ahrén, S. Sjöberg, J. Tuomilehto, M. Lind
{"title":"Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections","authors":"Sheyda Sofizadeh, Henrik Imberg, A. F. Ólafsdóttir, M. Ekelund, S. Dahlqvist, I. Hirsch, K. Filipsson, B. Ahrén, S. Sjöberg, J. Tuomilehto, M. Lind","doi":"10.1007/s13300-019-00692-1","DOIUrl":"https://doi.org/10.1007/s13300-019-00692-1","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"2115 - 2130"},"PeriodicalIF":3.8,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00692-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42756930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study 皮下注射低剂量胰高血糖素与口服葡萄糖治疗轻度低血糖的偏好:一项前瞻性调查研究
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-09-24 DOI: 10.1007/s13300-019-00696-x
Rikke Tetzschner, A. Ranjan, S. Schmidt, K. Nørgaard
{"title":"Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study","authors":"Rikke Tetzschner, A. Ranjan, S. Schmidt, K. Nørgaard","doi":"10.1007/s13300-019-00696-x","DOIUrl":"https://doi.org/10.1007/s13300-019-00696-x","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"2107 - 2113"},"PeriodicalIF":3.8,"publicationDate":"2019-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00696-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43999541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of Individualized Dietary Intervention on Oxidative Stress in Patients with Type 2 Diabetes Complicated by Tuberculosis in Xinjiang, China 个体化饮食干预对新疆2型糖尿病合并结核病患者氧化应激的影响
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-09-19 DOI: 10.1007/s13300-019-00691-2
Liyun He, Guoming Zhang, M. Wei, Yanjun Zhao, Weixing Chen, Qiaojun Peng, Guiyun Meng
{"title":"Effect of Individualized Dietary Intervention on Oxidative Stress in Patients with Type 2 Diabetes Complicated by Tuberculosis in Xinjiang, China","authors":"Liyun He, Guoming Zhang, M. Wei, Yanjun Zhao, Weixing Chen, Qiaojun Peng, Guiyun Meng","doi":"10.1007/s13300-019-00691-2","DOIUrl":"https://doi.org/10.1007/s13300-019-00691-2","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"2095 - 2105"},"PeriodicalIF":3.8,"publicationDate":"2019-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00691-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44544316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study 在没有α-葡萄糖苷酶抑制剂治疗的2型糖尿病患者餐后,加格列净可提高餐后总胰高血糖素样肽1水平:一项单臂、非随机、开放标签研究
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-09-10 DOI: 10.1007/s13300-019-00689-w
T. Osonoi, A. Tamasawa, Yusuke Osonoi, Kensuke Ofuchi, M. Katoh, M. Saito
{"title":"Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study","authors":"T. Osonoi, A. Tamasawa, Yusuke Osonoi, Kensuke Ofuchi, M. Katoh, M. Saito","doi":"10.1007/s13300-019-00689-w","DOIUrl":"https://doi.org/10.1007/s13300-019-00689-w","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"2045 - 2059"},"PeriodicalIF":3.8,"publicationDate":"2019-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00689-w","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49285540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study) 家庭成员:糖尿病护理团队中被遗忘的参与者(TALK-HYPO研究)
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-09-09 DOI: 10.1007/s13300-019-00687-y
A. Ratzki-Leewing, Ehsan Parvaresh Rizi, S. Harris
{"title":"Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study)","authors":"A. Ratzki-Leewing, Ehsan Parvaresh Rizi, S. Harris","doi":"10.1007/s13300-019-00687-y","DOIUrl":"https://doi.org/10.1007/s13300-019-00687-y","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"2305 - 2311"},"PeriodicalIF":3.8,"publicationDate":"2019-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00687-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42113489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin 天冬氨酸速效胰岛素:一种新型肉用胰岛素的原理
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-09-04 DOI: 10.1007/s13300-019-00685-0
M. Evans, Mathew Wilkinson, Angeliki Giannpolou
{"title":"Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin","authors":"M. Evans, Mathew Wilkinson, Angeliki Giannpolou","doi":"10.1007/s13300-019-00685-0","DOIUrl":"https://doi.org/10.1007/s13300-019-00685-0","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"1793 - 1800"},"PeriodicalIF":3.8,"publicationDate":"2019-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00685-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42765766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Meta-Analysis and Cost-Effectiveness Analysis of Insulin Glargine 100 U/mL Versus Insulin Degludec for the Treatment of Type 2 Diabetes in China 中国100u /mL甘精胰岛素与葡糖精胰岛素治疗2型糖尿病的meta分析和成本-效果分析
IF 3.8 3区 医学
Diabetes Therapy Pub Date : 2019-09-03 DOI: 10.1007/s13300-019-00683-2
Wenjun Su, Chaoyun Li, Lei Zhang, Ziyi Lin, Jun Tan, J. Xuan
{"title":"Meta-Analysis and Cost-Effectiveness Analysis of Insulin Glargine 100 U/mL Versus Insulin Degludec for the Treatment of Type 2 Diabetes in China","authors":"Wenjun Su, Chaoyun Li, Lei Zhang, Ziyi Lin, Jun Tan, J. Xuan","doi":"10.1007/s13300-019-00683-2","DOIUrl":"https://doi.org/10.1007/s13300-019-00683-2","url":null,"abstract":"","PeriodicalId":48675,"journal":{"name":"Diabetes Therapy","volume":"10 1","pages":"1969 - 1984"},"PeriodicalIF":3.8,"publicationDate":"2019-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13300-019-00683-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46017083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信